Moxifloxacin-d3

• 常用名: Moxifloxacin-d3
• 英文名: Moxifloxacin-d3
• CAS号: 1092356-42-7
• 分子量: 404.45
• 密度: N/A
• 沸点: N/A
• 分子式: C₂₁H₂₁D₃FN₃O₄
• 熔点: N/A
• 闪点: N/A

Moxifloxacin-d3用途

莫西沙星-d3是氘标记的莫西沙星。莫西沙星是一种口服活性8-甲氧基喹诺酮类抗生素,用于治疗急性细菌性鼻窦炎、慢性支气管炎急性细菌性加重和社区获得性肺炎。

Moxifloxacin-d3名称

• 英文名: Moxifloxacin-d3

Moxifloxacin-d3生物活性

• 描述: 莫西沙星-d3是氘标记的莫西沙星。莫西沙星是一种口服活性8-甲氧基喹诺酮类抗生素,用于治疗急性细菌性鼻窦炎、慢性支气管炎急性细菌性加重和社区获得性肺炎。
• 相关类别:
  研究领域 >> 感染
  信号通路 >> 抗感染 >> 细菌
• 体外研究: 氢、碳和其他元素的稳定重同位素已被纳入药物分子,主要作为药物开发过程中定量的示踪剂。氘化因其可能影响药物的药代动力学和代谢特征而受到关注[1]。
• 参考文献:

  [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-223.

  [2]. Culley, C.M., et al., Moxifloxacin: clinical efficacy and safety. Am J Health Syst Pharm, 2001. 58(5): p. 379-88.

  [3]. Grayo S, et al. Comparison of the in vitro efficacies of moxifloxacin and amoxicillin against Listeria monocytogenes. Antimicrob Agents Chemother. 2008 May;52(5):1697-702.

  [4]. Balfour JA, et al. Moxifloxacin: a review of its clinical potential in the management of community-acquired respiratory tract infections. Drugs. 2000 Jan;59(1):115-39.

  [5]. Ioannidis O, et al. Effect of moxifloxacin on survival, lipid peroxidation and inflammation in immunosuppressed rats with soft tissue infection caused by Stenotrophomonas maltophilia. Microbiol Immunol. 2014 Feb;58(2):96-102.

Moxifloxacin-d3物理化学性质

• 分子式: C₂₁H₂₁D₃FN₃O₄
• 分子量: 404.45